Sign In

Rajesh Gupta

Developing therapeutics and vaccines for global infectious diseases

Rajesh Gupta is a highly accomplished professional with over 20 years of experience in global infectious diseases, focusing on a wide range of pathogens like HIV, TB, malaria, and coronaviruses. His expertise includes portfolio strategy, regulatory approvals, fundraising, partnership development, and program implementation. He has a strong background in leading cross-functional teams, conducting clinical trials, and contributing to scientific publications. Rajesh holds a diverse educational background, including a Doctor of Medicine from Stanford University School of Medicine and degrees from Yale School of Medicine and Tulane University.

Highlights

May 21 · linkedin

Gavin Yamey and colleagues released an important report on how to improve the #globalhealth research and development ecosystem for low- and middle-income countries (LMICs), which includes an in-depth analysis (Section 5.2) of #monoclonalantibodies (mAbs). One conclusion is mAbs can be a game-changing technology for patients globally, but only if there is a concerted investment in pilot use cases to rapidly learn and adjust strategies for successful implementation and scale-up – a successful tactic historically used with small molecule therapeutics (which were novel technologies at that time) in #HIV/AIDS and drug-resistant #tuberculosis. Happy to have been one of several people who provided insights for the researchers involved in this effort.

Report link:

Oct 20 · linkedin

Thank you, TAG TREATMENT ACTION GROUP INC, for last night’s inspiring Research in Action Awards 2023 event. I’m proud that we at Vir Biotechnology, Inc. helped sponsor this event recognizing individuals at the forefront of the fight to end #HIV, #TB and viral hepatitis in the U.S. and globally.

Rajesh Gupta
Add to my network

Location

San Francisco Bay Area